Stockscreener 앱 받기
0.00
100.00%
-0.2001
시간 외 거래:
.18
0.18
+
전일 마감가:
$0.2001
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$13.94M
수익:
-
순이익/손실:
$-52.53M
주가수익비율:
0.00
EPS:
-3.66
순현금흐름:
$-39.93M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$3.10
Unity Biotechnology Inc Stock (UBX) Company Profile
명칭
Unity Biotechnology Inc
전화
(650) 416-1192
주소
285 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA
UBX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
UBX
Unity Biotechnology Inc
|
0.00 | 13.94M | 0 | -52.53M | -39.93M | -3.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
403.30 | 104.83B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
600.00 | 63.59B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.35 | 60.43B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
800.00 | 48.45B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
343.87 | 37.91B | 4.56B | -176.77M | 225.30M | -1.7177 |
Unity Biotechnology Inc Stock (UBX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-27 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2025-05-16 | 다운그레이드 | Mizuho | Outperform → Neutral |
| 2024-08-22 | 개시 | Rodman & Renshaw | Buy |
| 2023-11-16 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2022-01-04 | 업그레이드 | ROTH Capital | Neutral → Buy |
| 2021-11-10 | 업그레이드 | Mizuho | Neutral → Buy |
| 2021-06-28 | 업그레이드 | Citigroup | Sell → Buy |
| 2021-06-07 | 개시 | H.C. Wainwright | Buy |
| 2021-02-16 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2020-08-18 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-08-18 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2020-08-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-08-17 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2020-07-28 | 개시 | ROTH Capital | Buy |
| 2019-12-12 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-03-07 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-09-07 | 개시 | Mizuho | Buy |
| 2018-05-29 | 개시 | Citigroup | Buy |
| 2018-05-29 | 개시 | Goldman | Neutral |
| 2018-05-29 | 개시 | Morgan Stanley | Overweight |
모두보기
Unity Biotechnology Inc 주식(UBX)의 최신 뉴스
Is Unity Biotechnology Inc. stock a defensive play in 2025Weekly Gains Summary & Risk Adjusted Buy/Sell Alerts - newser.com
How Unity Biotechnology Inc. stock benefits from tech adoption2025 Key Lessons & Smart Money Movement Tracker - newser.com
Backtesting results for Unity Biotechnology Inc. trading strategiesIndex Update & Fast Entry High Yield Stock Tips - newser.com
How to monitor Unity Biotechnology Inc. with trend dashboardsPortfolio Risk Summary & Technical Pattern Based Buy Signals - newser.com
Can Unity Biotechnology Inc. rally from current levelsQuarterly Profit Review & Low Drawdown Momentum Trade Ideas - newser.com
How moving averages guide Unity Biotechnology Inc. tradingPortfolio Update Summary & Daily Stock Trend Watchlist - newser.com
Unity Biotechnology Inc Stock Analysis and ForecastFederal Reserve Announcements & Low Risk Wealth Plans - earlytimes.in
Unity Biotechnology files for dissolution and ends lease agreements By Investing.com - Investing.com Nigeria
Unity Biotechnology files for dissolution and ends lease agreements - Investing.com
Unity Biotechnology Files Dissolution Certificate Amid Cost-Cutting - TipRanks
Published on: 2025-09-20 22:56:38 - خودرو بانک
What indicators show strength in Unity Biotechnology Inc.2025 Market Outlook & Fast Momentum Stock Entry Tips - newser.com
Pharma News: Can Unity Biotechnology Inc sustain its profitability2025 Investor Takeaways & Reliable Price Breakout Signals - خودرو بانک
Unity Biotechnology stockholders approve company liquidation and dissolution plan By Investing.com - Investing.com Canada
Candlestick signals on Unity Biotechnology Inc. stock today2025 Support & Resistance & Stock Market Timing Techniques - newser.com
Unity Biotechnology stockholders approve company liquidation and dissolution plan - Investing.com India
Unity Biotechnology Approves Company Liquidation Plan - TipRanks
Unity Biotechnology Inc (UBX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.68%
0.38%
자본화:
|
볼륨(24시간):